Phase 2 Urinary Bladder Cancer Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
Urothelial CancerUrinary Bladder CancerUpper Tract Urothelial Cancer
Rutgers, The State University of New Jersey28 enrolled1 locationNCT06822010
Recruiting
Phase 2
Intravesical Gem/Doce in Patients With NMIBC
Urinary Bladder Cancer
University of Arizona25 enrolled1 locationNCT05644041
Recruiting
Phase 2
Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects
Urinary Bladder Cancer
Zhujiang Hospital41 enrolled1 locationNCT04861584
Recruiting
Phase 1Phase 2
A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study
Urinary Bladder CancerInvasive Bladder Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)50 enrolled3 locationsNCT03844256
Recruiting
Phase 2
Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer
Bladder CancerUrinary Bladder CancerBladder Neoplasms+2 more
Peking University First Hospital54 enrolled1 locationNCT05072600